Cell Reprogramming Work Wins Nobel

John B. Gurdon and Shinya Yamanaka jointly take home this year’s Nobel Prize in Medicine for turning back the developmental clock.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wikimedia, Nissim BenvenistyThe 2012 Nobel Prize for Physiology or Medicine goes to John B. Gurdon of the Gurdon Institute in Cambridge and Shinya Yamanaka of Kyoto University in Japan for their work showing that specialized cells can be reprogrammed to undifferentiated cells, capable of developing into any cell type in the body, The Nobel Assembly at Karolinska Institute announced this morning (October 8) from Stockholm.

Gurdon, often referred to as “the godfather of cloning,” published a landmark 1962 study in Journal of Embryology and Experimental Morphology showing that replacing the nucleus of a frog’s egg with the nucleus from an adult frog cell resulted in a functional, cloned tadpole. The finding proved that adult cells maintain an ability to mediate embryonic development, despite having already reaching their developmental fate.

More than 40 years later, Shinya Yamanaka discovered that four genes are capable of reprogramming an adult mouse cell into a cell in an embryonic stem cell-like state—called an induced pluripotent stem (iPS) cell—which can differentiate into any cell type. The 2006 finding, published in Cell, provides researchers with the genetic recipe to generate iPS cells from mature cells in mice ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies